Skip to main content
. 2018 Mar;6(2):213–224. doi: 10.1177/2050640617716607

Figure 3(a).

Figure
3(a).

SVR12 rates of the most frequently used approved antiviral regimens (effectiveness population, ITT3).

ITT: intention-to-treat; SOF: sofosbuvir; IFN: interferon; RBV: ribavirin; SIM: simeprevir; DCV: daclatasvir; LDV: ledipasvir; OBV: ombitasvir; PTV/r: paritaprevir/ritonavir; DSV: dasabuvir. Because of different baseline characteristics, SVR12 rates cannot be directly compared to each other.